Bill Gates’ is about to mint millionaires (again) with Stargate.

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

David A. Jones, Jr. net worth and biography

David Jones, Jr. Biography and Net Worth

Director of Humana

David A. Jones, Jr. was initially elected to the Board in May 1993 and served as Chairman of the Board of the Company from April 2005 through August 2010, and Vice Chairman of the Board from September 1996 through April 2005. He is Chairman of Chrysalis Ventures, LLC, headquartered in Louisville, Kentucky, and also serves on the board of directors of several private companies.

As a successful venture capitalist, the Board believes that Mr. Jones brings strategic insight and leadership and a wealth of experience in health care to the Board, both in the Company’s core businesses as well as in emerging technologies and business models.

What is David A. Jones, Jr.'s net worth?: The estimated net worth of David A. Jones, Jr. is at least $11.45 million as of December 21st, 2022. Mr. Jones, Jr. owns 42,028 shares of Humana stock worth more than $11,446,746 as of November 18th. This net worth approximation does not reflect any other assets that Mr. Jones, Jr. may own. Learn More about David A. Jones, Jr.'s net worth.
How do I contact David A. Jones, Jr.?: The corporate mailing address for Mr. Jones, Jr. and other Humana executives is 500 West Main Street, LOUISVILLE KY, 40202. Humana can also be reached via phone at (502) 580-1000 and via email at [email protected]. Learn More on David A. Jones, Jr.'s contact information.
Has David A. Jones, Jr. been buying or selling shares of Humana?: David A. Jones, Jr. has not been actively trading shares of Humana during the past quarter. Most recently, David A. Jr/Ky Jones sold 15,000 shares of the business's stock in a transaction on Wednesday, December 21st. The shares were sold at an average price of $501.72, for a transaction totalling $7,525,800.00. Following the completion of the sale, the director now directly owns 42,028 shares of the company's stock, valued at $21,086,288.16. Learn More on David A. Jones, Jr.'s trading history.
Who are Humana's active insiders?: Humana's insider roster includes Roy Beveridge (Insider), Jody Bilney (Insider), Bruce Broussard (CEO), M. Christopher (Insider), Samir Deshpande (Insider), Susan Diamond (CFO), William Fleming (CAO), Christopher Hunter (Insider), Timothy Huval (Insider), David Jones, Jr. (Director), Heidi Margulis (Insider), Jorge Mesquita (Director), James Murray (COO), Joseph Ventura (Insider), and Timothy Wheatley (Insider). Learn More on Humana's active insiders.
Are insiders buying or selling shares of Humana?: During the last twelve months, Humana insiders bought shares 1 times. They purchased a total of 545 shares worth more than $200,064.05. The most recent insider tranaction occured on February, 20th when Director Jorge S Mesquita bought 545 shares worth more than $200,064.05. Insiders at Humana own 0.3% of the company. Learn More about insider trades at Humana.
Information on this page was last updated on 2/20/2024.

David A. Jones, Jr. Insider Trading History at Humana

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/21/2022	Sell	15,000	$501.72	$7,525,800.00	42,028
9/16/2021	Sell	4,800	$401.00	$1,924,800.00
12/17/2020	Sell	5,000	$392.76	$1,963,800.00
3/20/2020	Sell	5,800	$256.19	$1,485,902.00
11/16/2018	Sell	600	$88.05	$52,830.00
8/11/2018	Sell	200	$120.24	$24,048.00
6/10/2018	Sell	400	$124.49	$49,796.00
5/18/2018	Sell	200	$230.04	$46,008.00
3/16/2018	Sell	400	$86.32	$34,528.00
2/21/2017	Sell	27,000	$205.04	$5,536,080.00
2/25/2015	Sell	6,100	$165.39	$1,008,879.00

David A. Jones, Jr. Buying and Selling Activity at Humana

Humana Company Overview

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Today's Range

Now: $272.36

$271.84

$279.43

50 Day Range

MA: $281.36

$236.27

$346.42

2 Week Range

Now: $272.36

$213.31

$527.18

Volume

407,393 shs

Average Volume

1,868,428 shs

Market Capitalization

$32.80 billion

P/E Ratio

24.12

Dividend Yield

1.25%

Beta

0.52